2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Dual Antiplatelet TherapyIs It Time to Cut the Cord With Aspirin?
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy JACC Guideline Comparison: JACC State-of-the-Art Review
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months versus aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicenter, open-label, randomized superiority trial
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.